Dichloroacetic Acid Storage — DCA Tank Selection

Dichloroacetic Acid Storage — CHCl₂COOH Tank Selection for Pharmaceutical, Peptide Synthesis, Investigational Therapy, and Chloroacetate Process Use

Dichloroacetic acid (DCA, CHCl₂COOH, CAS 79-43-6) is a colorless liquid (or 50% aqueous solution at industrial scale) with strong-acid character (pKa 1.29) intermediate between trichloroacetic acid (TCA, pKa 0.66) and monochloroacetic acid (MCA, pKa 2.86). Specific gravity of pure liquid 1.56, melting point 9.7°C, boiling point 194°C with decomposition. The 50% aqueous solution is the dominant industrial supply form: SG 1.30, freezing point -5°C, NOT flammable. The molecule exhibits an unusual pharmacological profile that drives its specialty-chemistry market: DCA inhibits the enzyme pyruvate dehydrogenase kinase (PDK), shifting cellular metabolism from glycolysis toward oxidative phosphorylation, with active investigational research as a metabolic-cancer therapeutic for PDH-deficient tumors and lactic acidosis. Global DCA production is dominated by CABB Group (Germany, ~28% global market share) with Chinese-domestic-production through Hebei Huadong Chemical, Changzhou Wujin Changshen Chemical, and MedicalChem (Yancheng) accounting for over 45% of global capacity.

This pillar covers tank-system specification for DCA in pharmaceutical / investigational-therapy service, peptide-synthesis (Boc-deprotection chemistry), chloroacetate-herbicide intermediate manufacturing, and water-treatment disinfection-byproduct (DBP) analysis applications. The six sections below cite CABB Group + Laxmi Organic Industries product specifications. Regulatory citations point to OSHA 29 CFR 1910.1200 hazcom (no formal PEL but recognized hazardous), ACGIH no formal TLV, DOT UN 1764 Hazard Class 8 (Corrosive) Packing Group II, EPA Drinking Water Regulation Stage 2 DBPR (DBP haloacetic-acids 5 group, including DCA, MCL 60 μg/L), and IARC Monograph Vol. 106 Group 2B (possibly carcinogenic).

1. Material Compatibility Matrix

DCA at the 50% aqueous solution form is highly aggressive on metals and many plastics due to its strong-acid character (pKa 1.29) combined with chloride-ion availability for pitting attack. Compatibility profile is similar to TCA with mild differences in metal pitting kinetics. 316L stainless is generally acceptable but exhibits faster corrosion than for typical organic-acid service; HDPE and PP are the standard plastic options. Carbon-steel and aluminum are NOT compatible.

Industrial 50% DCA solution storage is overwhelmingly HDPE/XLPE rotomolded tanks with PP fittings and EPDM/Viton gaskets — the same plastic-tank specification used for TCA and similar strong-acid solution-storage service. Pure-liquid DCA is shipped in HDPE drums and totes; pharmaceutical-grade product is shipped in glass-lined or Hastelloy C-276 transit tanks for trace-metal control.

2. Real-World Industrial Use Cases

Peptide Synthesis — Boc Deprotection Reagent. DCA at 1-3% concentration in dichloromethane (DCM) is a standard reagent for tert-butoxycarbonyl (Boc) protecting-group removal in solid-phase peptide synthesis (SPPS) for peptide-pharmaceutical manufacturing (insulin analogs, GLP-1 agonists, oxytocin). DCA is the milder alternative to trifluoroacetic acid (TFA) Boc-deprotection for acid-sensitive peptide sequences. Plant-scale DCA inventory at peptide contract-manufacturing operations (Bachem, Polypeptide, Lonza) is typically 200-2,000 gallon HDPE storage tanks dispensed via metering pumps to SPPS-reactor solvent-feed loops.

Investigational Pharmaceutical — Cancer Metabolic Therapy. DCA inhibits pyruvate dehydrogenase kinase (PDK), reactivating mitochondrial oxidative phosphorylation in cancer cells that have shifted to aerobic glycolysis (Warburg effect). Investigational clinical trials at the University of Alberta, University of Florida, and other research centers continue to evaluate DCA in glioblastoma, head-and-neck cancers, and pediatric PDH-deficient lactic acidosis. The investigational-pharmaceutical supply chain uses USP-grade DCA in small-volume vials/bottles rather than tank-scale industrial inventory.

Pediatric Lactic Acidosis — Pyruvate Dehydrogenase Deficiency. DCA (sodium dichloroacetate, the salt form) is an FDA-approved orphan drug for treating congenital lactic acidosis in pediatric patients with pyruvate dehydrogenase complex (PDC) deficiency. The orphan-drug supply uses USP-grade material in small-vial pharmaceutical-distribution scale rather than industrial tank-scale.

Chloroacetate-Herbicide Intermediate. DCA + sodium hydroxide produces sodium dichloroacetate, an intermediate in some chloroacetamide herbicide synthesis pathways (alachlor, metolachlor, propachlor — though most modern production uses MCA-route chemistry). Plant-scale DCA inventory at herbicide-active-ingredient producers is typically 5,000-20,000 gallon HDPE tanks adjacent to the chloroacetamide-synthesis batch reactor.

Water-Treatment DBP Standards. DCA is one of the five regulated haloacetic acids (HAA5: monochloroacetic, dichloroacetic, trichloroacetic, monobromoacetic, dibromoacetic) under EPA's Stage 2 Disinfection Byproducts Rule. HAA5 monitoring at municipal water-treatment plants is mandatory (sampling in the distribution system, MCL 60 μg/L). The DCA used in this context is analytical-standard grade rather than process-bulk.

Specialty Fine-Chemical Synthesis. DCA serves as a chlorinated-acetate source in fine-chemical synthesis: glycolic-acid synthesis via DCA hydrolysis is one route at smaller specialty producers. Pharmaceutical contract-synthesis operations maintain modest DCA inventory (250-1,000 gal HDPE totes/drums) at fine-chemical batch facilities.

3. Regulatory Hazard Communication

OSHA Hazcom and ACGIH TLV. OSHA 29 CFR 1910.1200 classifies DCA as a hazardous substance (corrosive + acute toxicity Category 4); no formal OSHA PEL has been established. ACGIH has not assigned a formal TLV; manufacturer-recommended exposure limits typically apply 0.5 ppm 8-hour TWA by analogy to similar chloroacetic acids. Personal-protection requirements include full-face air-purifying respirator at any sustained vapor exposure, acid-resistant Tychem suit, neoprene gloves, and chemical splash goggles for any direct-contact handling.

NFPA 704 Diamond. DCA rates NFPA Health 3 (very dangerous corrosive), Flammability 0 (not flammable), Instability 1 (mild reactivity), with Special Hazard ALK (alkalinity-reactive). The Health 3 rating drives the dominant safety design consideration: full-body PPE plus eyewash/safety-shower at any storage or transfer station.

IARC Carcinogen Classification. IARC Monograph Vol. 106 (2014) classifies dichloroacetic acid as Group 2B (possibly carcinogenic to humans) based on rodent liver-tumor evidence. The classification is similar to TCA and reflects scientific uncertainty about human-carcinogen potency at typical workplace and drinking-water exposures. California Proposition 65 lists DCA as a developmental toxicant; California-distributed product requires Prop 65 warning labels.

FDA Orphan Drug Status. Sodium dichloroacetate is FDA-approved orphan-drug designation for congenital pyruvate dehydrogenase deficiency lactic acidosis. The orphan-drug supply chain operates under cGMP requirements with pharmaceutical-grade USP material specifications. Pharmaceutical-grade DCA (USP) is significantly more expensive than technical-grade and requires additional supply-chain documentation and traceability.

DOT and Shipping. Pure DCA liquid ships under UN 1764, Hazard Class 8 (Corrosive), Packing Group II. 50% DCA solution ships under the same UN 1764 designation. Bulk solution shipping requires DOT-407 stainless tankers OR HDPE cargo tanks (acid-service-certified) with hazmat-trained drivers and corrosive-class placarding. Drum and tote shipping requires UN-rated steel or composite IBCs with proper Class 8 labeling.

EPA Drinking-Water DBP Regulation. Stage 2 Disinfection Byproducts Rule (40 CFR 141 Subpart V) sets MCL for HAA5 (haloacetic-acids 5-group, including DCA) at 60 μg/L on a locational running annual average basis. The DBP regulation drives water-treatment-plant disinfection-process optimization to meet the MCL.

EPCRA Tier II. DCA is on EPCRA Section 312 Tier II hazardous chemical reporting list at 10,000 lb threshold quantity. Most industrial plant inventories of 50% DCA solution exceed this threshold and trigger annual Tier II reporting.

4. Storage System Specification

Tank Construction. Industrial 50% DCA solution storage uses HDPE rotomolded tanks (1.5-1.9 SG-rated) for bulk storage at 200-5,000 gallon scale. PP fittings, EPDM/Viton gaskets, and PVC bulkhead unions are standard. For pharmaceutical USP-grade or specialty-chemical-grade service, Hastelloy C-276 or titanium tanks may be specified at small (200-1,000 gallon) plant-inventory scale; this is most common at peptide contract-manufacturing operations where trace-metal contamination must be minimized to avoid SPPS side reactions. Carbon steel, aluminum, and copper alloys are PROHIBITED in the wetted system.

Temperature Considerations. Pure DCA freezes at 9.7°C (similar to glacial acetic acid risk). 50% DCA solution freezes at -5°C (similar to TCA). Pure-liquid DCA storage requires heat-trace tape on tanks and piping during typical climate-controlled-warehouse temperature ranges (above 12°C target); 50% solution may operate without freeze-protection in most US climates.

Vapor Control. 50% DCA solution has very low vapor pressure (DCA is essentially non-volatile compared to dilute mineral acids); standard HDPE tank vents (atmospheric breather) are adequate. The non-flammable classification eliminates fire-protection design considerations that drive flammable-acid storage practice.

Secondary Containment. Per 40 CFR 112 SPCC, above-ground DCA storage tanks above 1,320 gallons aggregate require secondary containment sized to 110% of largest tank capacity. The Class 8 Corrosive classification drives concrete dike specification with acid-resistant epoxy coating; standard SPCC plans include detailed spill-response procedures with sodium-bicarbonate or soda-ash neutralization.

Pump Selection. 50% DCA solution transfer pumps are typically magnetic-drive centrifugal (CDR Pumps, Iwaki, Finish Thompson) with PTFE/Viton wetted parts in PP or PVDF casings. Diaphragm metering pumps (LMI, Pulsafeeder, Grundfos) handle smaller dosing volumes at pharmaceutical-laboratory scale.

Piping. Industrial DCA piping is Schedule 80 PVC or CPVC with EPDM gaskets; Schedule 80 PP for elevated-temperature service. PVDF piping for high-purity pharmaceutical service. Stainless-piping is acceptable but offers no compatibility advantage over plastic at typical 50% solution service. Carbon steel and copper-alloy pipe are NOT acceptable.

5. Field Handling Reality

The Pure-Liquid Freezing Reality. Pure DCA freezes at 9.7°C, well within typical climate-controlled-warehouse temperature ranges. A frozen-solid pure-DCA tank takes 8-16 hours to thaw with steam jacket or glycol-loop heat input. 50% DCA solution storage avoids this problem entirely (-5°C freezing point). Industrial buyers should specify 50% solution shipment unless pure-liquid form is required for specific synthesis chemistry.

Strong-Acid Handling. 50% DCA solution at pH below 1.0 is more aggressive on skin than dilute hydrochloric acid; immediate severe burns on skin contact + permanent eye damage on direct exposure are the standard hazards. Standard PPE for any direct-contact handling includes acid-resistant Tychem-suit + face-shield + chemical-goggles + neoprene/butyl rubber gloves. Spill-decontamination uses 1-2% sodium bicarbonate solution or copious water flush.

Decarboxylation under Heat. DCA decomposes thermally above 100°C to dichloromethane (CH₂Cl₂) + carbon dioxide. This decarboxylation is the dominant industrial-incident pathway for DCA storage: a tank-bottom heat-source incident drives dichloromethane vapor evolution from the contained solution, producing a Class 6.1 toxic-vapor cloud as a secondary hazard. Storage-system design avoids hot surfaces in DCA contact.

Spill Response. Liquid DCA solution spills are absorbed with sodium-bicarbonate or soda-ash dry powder for direct neutralization to sodium dichloroacetate + water + carbon dioxide. The sodium-dichloroacetate residue is a regulated organic chloride; disposal as RCRA F-listed waste may be required depending on quantity. Large-volume spills require professional emergency-response services with hazmat-rated vacuum trucks.

SPPS Side-Reaction Trace Metal Concern. Peptide-synthesis service requires trace-metal-controlled DCA (typically <1 ppm Fe, <0.5 ppm Cu, <0.5 ppm Ni). This is the practical reason peptide contract manufacturers use Hastelloy C-276 or titanium DCA storage rather than HDPE/stainless. Trace-metal contamination from carbon-steel pumping leads to peptide-side-reaction yield loss (typically 5-15% per contaminated batch).

Related Chemistries in the Organic Acid Cluster

Related chemistries in the organic acid cluster (food + cleaning + biodegradable chelation + fatty-acid + lipid-ester + carboxylic-acid chemistry):

• Trichloroacetic Acid (TCA) — Chloroacetic-acid sister chemistry
• Monochloroacetic Acid (MCAA) — Chloroacetic-acid sister chemistry
• Glacial Acetic Acid — Parent acetic-acid chemistry
• Acetic Acid (AcOH) — Parent acetic-acid chemistry
• Oxalic Acid — Strong organic-acid companion

Related Hub Pillars

For broader chemistry context, see the OneSource Plastics high-traffic chemical-compatibility hub pillars:

• Sulfuric Acid (H₂SO₄)
• Hydrochloric Acid (HCl / muriatic)
• Sodium Hydroxide (NaOH / caustic soda)